Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9Breast Neoplasms 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Acute 7Leukemia 7Congenital Abnormalities 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Multiple Myeloma 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sezary Syndrome 3Mycosis Fungoides 3Melanoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma 3Lung Neoplasms 3Leukemia, Myeloid, Accelerated Phase 3Hodgkin Disease 3

Interventions

enzalutamide 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lethal Congenital Contracture Syndrome 2 × In Situ Hybridization, Fluorescence × Clear all
NCT00740532 2010-09-02

Molecular Features Predicting Response/Resistance to Trastuzumab in Metastatic Breast Cancer Patients

Istituto Clinico Humanitas

Completed
11 enrolled
Breast

Lethal Congenital Contracture Syndrome 2, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡